恒瑞医药:HRS-3095片获临床试验批准

南方财经网
Aug 20

南财智讯8月20日电,恒瑞医药公告,HRS-3095片收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,同意开展原发免疫性血小板减少症(ITP)和自身免疫性溶血性贫血(AIHA)的临床试验。(文章来源:南方财经网)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10